-
Font Size:
-
Print
- TweetThis
GuidanceAnalysts are looking for a profit of 73c on revenue of 1.68B. The consensus range is 71c to 73c for EPS, and revenue of $1.65Bto $1.70B, according to First Call. Positive drivers for this quarters earnings is revenue growth in the orthopedic implant business and surgical instruments. Possible negative influences include unfavorable effects of product recalls and pricing pressures. In mid-March, the company reaffirmed FY08 guidance of EPS $2.88. Analyst ViewsOn May 9, Robert Baird said it was incrementally positive on the company's outlook. The firm continues to be confident in management's ability to overcome challenges in the near term while believing 20% earnings growth in FY08 and FY09 is attainable. Robert W Baird maintained its estimates with an $80 price target and an Outperform rating. | |||
Related Articles
|



Stryker Corp. (





















This article has 1 comment: